查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573028

体型雕塑市场：按治疗类型、技术、最终用户、应用、产品类型 - 全球预测 2025-2030

Body Contouring Market by Treatment Type (Invasive, Minimally Invasive, Non-Invasive), Technology (Cryolipolysis, Injectables, Laser), End-User, Application, Product Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年体型雕塑市场价值为3.5437亿美元，预计到2024年将达到3.8748亿美元，复合年增长率为11.62%，到2030年将达到7.6534亿美元。

体型雕塑包括旨在调整人体外观并使其更加美丽的各种医疗程序。这包括抽脂和腹部除皱术等手术技术，以及酷塑和雷射治疗等非手术治疗。肥胖率上升、美学意识增强以及非侵入性手术技术进步推动了世界对体型雕塑日益增长的需求。主要应用包括减脂、橘皮组织治疗、紧肤和活肤，以满足诊所、医院和水疗中心等客户的需求。随着越来越多的人将外表与健康放在一起，体型雕塑市场面临着巨大的成长机会。主要驱动因素包括提高安全性、缩短恢復时间以及提高所有性别和年龄的人对整容手术的接受度。然而，挑战依然存在。高额手术成本、严格的监管合规性以及手术干预的潜在副作用可能会阻碍市场成长。此外，不一致的经济状况可能会影响个人在整容手术上的可自由支配支出。儘管有这些障碍，该市场在亚太和拉丁美洲等地区仍有潜力，这些地区的中产阶级人口不断增长，可支配收入不断增加。公司应该透过扩大服务范围并投资冷冻溶脂和射频设备等先进技术来利用这些机会。在技​​术创新方面，市场参与者可以透过专注于客製化治疗以及整合人工智慧和机器学习来提高治疗效果来实现差异化。寻找无痛、高效且经济的手术也是一个有前景的领域。体型雕塑市场的本质是动态和竞争的，不断的创新推动市场的开拓。企业需要跟上消费趋势，利用数位行销并建立强大的客户教育管道，以巧妙地维持和扩大市场占有率。

主要市场统计
基准年[2023] 3.5437亿美元
预测年份 [2024] 38748万美元
预测年份 [2030] 76534万美元
复合年增长率（%） 11.62%

市场动态：揭示快速发展的体型雕塑市场的关键市场洞察

供需的动态交互作用正在改变体型雕塑市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 不断扩大的医疗旅游业推动了对负担得起的服务的需求
    • 肥胖和相关疾病发生率的增加增加了人们对体型雕塑的兴趣
    • 社群媒体和名人代言对促进体型雕塑治疗的影响
    • 开发创新的体型雕塑治疗方法，最大限度地减少停机时间并加快恢復速度
  • 市场限制因素
    • 潜在患者缺乏对体型雕塑治疗的认知与知识
    • 与体型雕塑手术相关的潜在健康风险会影响患者的信心
  • 市场机会
    • 透过提高新兴国家体型雕塑普及率开拓市场
    • 主要企业之间的策略联盟和收购可提高市场占有率和成长
    • 由于男性对体型雕塑手术的认识和接受度不断提高，新的细分市场得以创建
  • 市场挑战
    • 冷冻溶脂、超音波和雷射治疗等非侵入性减脂治疗的竞争日益激烈，影响市场占有率
    • 高额治疗费用和缺乏保险覆盖阻碍患者选择体型雕塑手术

波特五力：驾驭体型雕塑市场的策略工具

波特的五力是了解体型雕塑市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解体型雕塑市场的外在影响

外部宏观环境因素在体型雕塑市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解体型雕塑市场的竞争格局

对体型雕塑市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵体型雕塑市场厂商绩效评估

FPNV定位矩阵是评估体型雕塑市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製体型雕塑市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对体型雕塑市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医疗旅游业的扩张增加了对经济实惠的体型雕塑服务的需求
      • 肥胖及相关疾病发生率的上升增加了人们对体型雕塑的兴趣。
      • 社群媒体与名人代言对推广体型雕塑治疗的影响
      • 开发创新的体型雕塑治疗方法，最大限度地减少停机时间并确保快速恢復
    • 抑制因素
      • 潜在患者对体型雕塑手术的认知与了解有限
      • 与影响患者信心的体型雕塑手术相关的潜在健康风险
    • 机会
      • 由于采用率不断上升，新兴国家的体型雕塑手术市场不断扩大
      • 主要企业之间的策略联盟和收购增加了市场占有率和成长
      • 提高男性对体型雕塑手术的认识与接受度，创造新的市场
    • 任务
      • 来自冷冻、超音波疗法和雷射疗法等非侵入性减脂治疗的竞争日益激烈，正在影响市场占有率。
      • 由于费用高且缺乏保险，患者对选择体型雕塑手术犹豫不决。
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依治疗类型体型雕塑市场

  • 侵入性的
    • 下半身提升
    • 传统抽脂手术
    • 腹部手术
  • 微创
    • 雷射抽脂手术
    • 射频抽脂术
  • 非侵入性
    • 冷却脂分解
    • 高强度聚焦超音波（HIFU）
    • 雷射溶脂
    • 无线电频率

第七章体型雕塑市场：依技术分类

  • 冷却脂分解
  • 注射
  • 雷射
  • 无线电频率
  • 超音波

第八章体型雕塑市场：依最终用户分类

  • 医院
  • 医疗水疗
  • 专科诊所

第九章体型雕塑市场：依应用分类

  • 腹部
  • 武器
  • 身体和背部
  • 臀部
  • 大腿

第十章体型雕塑市场：依产品类型

  • 消耗品
  • 装置

第十一章 美洲体型雕塑市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太体型雕塑市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲体型雕塑市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0455

The Body Contouring Market was valued at USD 354.37 million in 2023, expected to reach USD 387.48 million in 2024, and is projected to grow at a CAGR of 11.62%, to USD 765.34 million by 2030.

Body contouring encompasses a range of medical procedures aimed at reshaping and enhancing the human body's appearance. It involves both surgical techniques, such as liposuction and tummy tucks, and non-surgical treatments, like CoolSculpting and laser therapy. The growing global demand for body contouring is fueled by increasing obesity rates, a rising aesthetic consciousness, and technological advancements in non-invasive procedures. Key applications include fat reduction, cellulite treatment, skin tightening, and skin rejuvenation, catering to clients in clinics, hospitals, and spas. As people increasingly prioritize their appearance alongside health, the body contouring market faces expansive growth opportunities. Significant drivers include improved safety profiles, minimal recovery time, and the increasing acceptance of aesthetic procedures across genders and age groups. However, challenges persist: high procedure costs, stringent regulatory compliance, and potential side effects from surgical interventions can inhibit market growth. Moreover, inconsistent economic conditions might impact individuals' discretionary spending on cosmetic procedures. Despite these hurdles, the market holds potential in regions like Asia-Pacific and Latin America due to burgeoning middle-class populations and increased disposable incomes. Businesses should capitalize on these opportunities by expanding service offerings and investing in advanced technologies like cryolipolysis and radiofrequency devices. For innovation, focusing on customizable treatments and integrating AI and machine learning to enhance procedural outcomes can differentiate market players. Research into pain-free, efficient, and economical procedures is another promising area. The nature of the body contouring market is dynamic and fiercely competitive, with continuous innovations driving market development. Businesses should maintain a keen understanding of consumer trends, leverage digital marketing, and establish strong customer education channels to maintain and expand their market share adeptly.

KEY MARKET STATISTICS
Base Year [2023] USD 354.37 million
Estimated Year [2024] USD 387.48 million
Forecast Year [2030] USD 765.34 million
CAGR (%) 11.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Body Contouring Market

The Body Contouring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expanding medical tourism industry driving demand for affordable body contouring services
    • Higher incidence of obesity and related conditions leading to increased interest in body contouring
    • Influence of social media and celebrity endorsements promoting body contouring treatments
    • Development of innovative body contouring treatments with minimal downtime ensuring quick recovery
  • Market Restraints
    • Limited awareness and knowledge about body contouring procedures among potential patients
    • Potential health risks associated with body contouring procedures affecting patient confidence
  • Market Opportunities
    • Emerging market for body contouring procedures in developing countries due to higher adoption rates
    • Strategic partnerships and acquisitions among key players leading to enhanced market share and growth
    • Rising awareness and acceptance of body contouring procedures among men creating new market segments
  • Market Challenges
    • Rising competition from non-invasive fat reduction treatments like cryolipolysis, ultrasound, and laser therapy impacting market share
    • High treatment costs and lack of insurance coverage discouraging patients from opting for body contouring procedures

Porter's Five Forces: A Strategic Tool for Navigating the Body Contouring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Body Contouring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Body Contouring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Body Contouring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Body Contouring Market

A detailed market share analysis in the Body Contouring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Body Contouring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Body Contouring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Body Contouring Market

A strategic analysis of the Body Contouring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Body Contouring Market, highlighting leading vendors and their innovative profiles. These include Aerolase, Allergan, Alma Lasers, BTL Aesthetics, Cutera, Cynosure, EndyMed, Fotona, Galderma, Hologic, InMode, Lumenis, Merz Pharma, Sciton, Solta Medical, Syneron Medical, ThermiGen, Valeant Pharmaceuticals, Venus Concept, and Zimmer Aesthetics.

Market Segmentation & Coverage

This research report categorizes the Body Contouring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Invasive, Minimally Invasive, and Non-Invasive. The Invasive is further studied across Lower Body Lift, Traditional Liposuction, and Tummy Tuck. The Minimally Invasive is further studied across Laser-Assisted Liposuction and Radiofrequency-Assisted Liposuction. The Non-Invasive is further studied across Cryolipolysis, High-Intensity Focused Ultrasound (HIFU), Laser Lipolysis, and Radiofrequency.
  • Based on Technology, market is studied across Cryolipolysis, Injectables, Laser, Radiofrequency, and Ultrasound.
  • Based on End-User, market is studied across Hospitals, Medical Spas, and Specialty Clinics.
  • Based on Application, market is studied across Abdomen, Arms, Body & Back, Buttocks, and Thighs.
  • Based on Product Type, market is studied across Consumables and Devices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expanding medical tourism industry driving demand for affordable body contouring services
      • 5.1.1.2. Higher incidence of obesity and related conditions leading to increased interest in body contouring
      • 5.1.1.3. Influence of social media and celebrity endorsements promoting body contouring treatments
      • 5.1.1.4. Development of innovative body contouring treatments with minimal downtime ensuring quick recovery
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and knowledge about body contouring procedures among potential patients
      • 5.1.2.2. Potential health risks associated with body contouring procedures affecting patient confidence
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging market for body contouring procedures in developing countries due to higher adoption rates
      • 5.1.3.2. Strategic partnerships and acquisitions among key players leading to enhanced market share and growth
      • 5.1.3.3. Rising awareness and acceptance of body contouring procedures among men creating new market segments
    • 5.1.4. Challenges
      • 5.1.4.1. Rising competition from non-invasive fat reduction treatments like cryolipolysis, ultrasound, and laser therapy impacting market share
      • 5.1.4.2. High treatment costs and lack of insurance coverage discouraging patients from opting for body contouring procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Body Contouring Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Invasive
    • 6.2.1. Lower Body Lift
    • 6.2.2. Traditional Liposuction
    • 6.2.3. Tummy Tuck
  • 6.3. Minimally Invasive
    • 6.3.1. Laser-Assisted Liposuction
    • 6.3.2. Radiofrequency-Assisted Liposuction
  • 6.4. Non-Invasive
    • 6.4.1. Cryolipolysis
    • 6.4.2. High-Intensity Focused Ultrasound (HIFU)
    • 6.4.3. Laser Lipolysis
    • 6.4.4. Radiofrequency

7. Body Contouring Market, by Technology

  • 7.1. Introduction
  • 7.2. Cryolipolysis
  • 7.3. Injectables
  • 7.4. Laser
  • 7.5. Radiofrequency
  • 7.6. Ultrasound

8. Body Contouring Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Medical Spas
  • 8.4. Specialty Clinics

9. Body Contouring Market, by Application

  • 9.1. Introduction
  • 9.2. Abdomen
  • 9.3. Arms
  • 9.4. Body & Back
  • 9.5. Buttocks
  • 9.6. Thighs

10. Body Contouring Market, by Product Type

  • 10.1. Introduction
  • 10.2. Consumables
  • 10.3. Devices

11. Americas Body Contouring Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Body Contouring Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Body Contouring Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aerolase
  • 2. Allergan
  • 3. Alma Lasers
  • 4. BTL Aesthetics
  • 5. Cutera
  • 6. Cynosure
  • 7. EndyMed
  • 8. Fotona
  • 9. Galderma
  • 10. Hologic
  • 11. InMode
  • 12. Lumenis
  • 13. Merz Pharma
  • 14. Sciton
  • 15. Solta Medical
  • 16. Syneron Medical
  • 17. ThermiGen
  • 18. Valeant Pharmaceuticals
  • 19. Venus Concept
  • 20. Zimmer Aesthetics

LIST OF FIGURES

  • FIGURE 1. BODY CONTOURING MARKET RESEARCH PROCESS
  • FIGURE 2. BODY CONTOURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BODY CONTOURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BODY CONTOURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BODY CONTOURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BODY CONTOURING MARKET DYNAMICS
  • TABLE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY LOWER BODY LIFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY TRADITIONAL LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY TUMMY TUCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER-ASSISTED LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY-ASSISTED LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER LIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BODY CONTOURING MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BODY CONTOURING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BODY CONTOURING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BODY CONTOURING MARKET SIZE, BY ARMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BODY CONTOURING MARKET SIZE, BY BODY & BACK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BODY CONTOURING MARKET SIZE, BY BUTTOCKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGHS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BODY CONTOURING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BODY CONTOURING MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 355. TURKEY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 356. TURKEY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 357. TURKEY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY APPLICATION